10x Genomics, Inc. (TXG) FY2026 Q2 Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
10x Genomics, Inc. (TXG) FY2026 Q2 Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current liabilities$118.51 MLiabilities$204.52 MNon-current liabilities$86.01 MCurrent assets$674.67 MEquity$825.55 MGross equity(calculated)$2.37 BAssets$1.03 BNon-current assets$355.40 MHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSCash and cash equivalentsInventoryMarketable securitiesAccounts receivable, netPrepaid expenses and other current assetsOther receivablesProperty and equipment, netIntangible assets, netOperating lease right-of-use assetsOther noncurrent assetsGoodwillAccrued expenses and other current liabilitiesAccrued compensation and related benefitsDeferred revenueAccounts payableOperating lease liabilitiesContingent consideration, currentOperating lease liabilities, noncurrentDeferred revenue, noncurrentOther noncurrent liabilitiesContingent consideration, noncurrentAdditional paid-in capitalAccumulated other comprehensive incomeCommon stockCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Accumulated deficitAccrued expenses and other current liabilitiesAccrued expenses and other current liabilities$30.38 MAccrued compensation and related benefitsAccrued compensation and related benefits$24.74 MCurrent liabilitiesCurrent liabilities$118.51 MDeferred revenueDeferred revenue$23.61 MAccounts payableAccounts payable$20.69 MLiabilitiesLiabilities$204.52 MOperating lease liabilitiesOperating lease liabilities$12.02 MContingent consideration, currentContingent consideration, current$7.07 MOperating lease liabilities, noncurrentOperating lease liabilities, noncurrent$66.78 MNon-current liabilitiesNon-current liabilities$86.01 MDeferred revenue, noncurrentDeferred revenue, noncurrent$9.68 MCurrent assetsCurrent assets$674.67 MOther noncurrent liabilitiesOther noncurrent liabilities$6.56 MCash and cash equivalentsCash and cash equivalents$502.51 MEquityEquity$825.55 MContingent consideration, noncurrentContingent consideration, noncurrent$2.99 MGross equity (calculated)Gross equity(calculated)$2.37 BAssetsAssets$1.03 BInventoryInventory$52.62 MMarketable securitiesMarketable securities$49.52 MAccounts receivable, netAccounts receivable, net$47.55 MPrepaid expenses and other current assetsPrepaid expenses and other current assets$19.39 MOther receivablesOther receivables$3.08 MProperty and equipment, netProperty and equipment, net$215.32 MNon-current assetsNon-current assets$355.40 MIntangible assets, netIntangible assets, net$61.16 MAdditional paid-in capitalAdditional paid-in capital$2.37 BOperating lease right-of-use assetsOperating lease right-of-use assets$56.69 MOther noncurrent assetsOther noncurrent assets$15.31 MGoodwillGoodwill$6.92 MAccumulated other comprehensive incomeAccumulated other comprehensive income$77.00 KCommon stockCommon stock$2.00 KAccumulated deficitAccumulated deficit−$1.54 B
Chart details

10x Genomics, Inc. (TXG) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
1,030,066,000 US dollars
Current assets
674,671,000 US dollars
Non-current assets
355,395,000 US dollars
Liabilities
204,520,000 US dollars
Current liabilities
118,509,000 US dollars
Non-current liabilities
86,011,000 US dollars
Equity
825,546,000 US dollars
Cash and cash equivalents
502,512,000 US dollars
Inventory
52,616,000 US dollars
Marketable securities
49,521,000 US dollars
Accounts receivable, net
47,545,000 US dollars
Prepaid expenses and other current assets
19,393,000 US dollars
Other receivables
3,084,000 US dollars
Property and equipment, net
215,324,000 US dollars
Intangible assets, net
61,160,000 US dollars
Operating lease right-of-use assets
56,685,000 US dollars
Other noncurrent assets
15,308,000 US dollars
Goodwill
6,918,000 US dollars
Accrued expenses and other current liabilities
30,377,000 US dollars
Accrued compensation and related benefits
24,744,000 US dollars
Deferred revenue
23,610,000 US dollars
Accounts payable
20,694,000 US dollars
Operating lease liabilities
12,015,000 US dollars
Contingent consideration, current
7,069,000 US dollars
Operating lease liabilities, noncurrent
66,781,000 US dollars
Deferred revenue, noncurrent
9,683,000 US dollars
Other noncurrent liabilities
6,556,000 US dollars
Contingent consideration, noncurrent
2,991,000 US dollars
Additional paid-in capital
2,367,459,000 US dollars
Accumulated other comprehensive income
77,000 US dollars
Common stock
2,000 US dollars
Preferred stock
0 US dollars
Accumulated deficit
negative 1,541,992,000 US dollars
Gross equity (calculated)
2,367,538,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
10x Genomics, Inc. (TXG) FY2026 Q2 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!